sb 203580 has been researched along with mifepristone in 3 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (mifepristone) | Trials (mifepristone) | Recent Studies (post-2010) (mifepristone) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 6,536 | 595 | 1,758 |
Protein | Taxonomy | sb 203580 (IC50) | mifepristone (IC50) |
---|---|---|---|
Glucocorticoid receptor | Canis lupus familiaris (dog) | 0.0264 | |
Bile salt export pump | Homo sapiens (human) | 2.02 | |
Estrogen receptor | Homo sapiens (human) | 4.311 | |
Glucocorticoid receptor | Homo sapiens (human) | 0.0249 | |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.0003 | |
Progesterone receptor | Homo sapiens (human) | 0.1347 | |
Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.774 | |
Glucocorticoid receptor | Mus musculus (house mouse) | 0.0022 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0022 | |
Mineralocorticoid receptor | Homo sapiens (human) | 2.0938 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 9.5 | |
Coagulation factor VII | Homo sapiens (human) | 0.0003 | |
Androgen receptor | Homo sapiens (human) | 0.2988 | |
Cytochrome P450 2C8 | Homo sapiens (human) | 1.5 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 4.9 | |
Steroid 17-alpha-hydroxylase/17,20 lyase | Rattus norvegicus (Norway rat) | 0.0016 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 0.555 | |
Tissue factor | Homo sapiens (human) | 0.0003 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.0083 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0014 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.0022 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0022 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.0078 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0022 | |
Substance-P receptor | Cavia porcellus (domestic guinea pig) | 0.0015 | |
Mu-type opioid receptor | Homo sapiens (human) | 2.457 | |
Estrogen receptor beta | Homo sapiens (human) | 1.528 | |
Glucocorticoid receptor | Sus scrofa (pig) | 0.0153 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YP; Luo, Y; Rui, HL | 1 |
Chen, Y; Feng, C; Xiao, L | 1 |
Harada, H; Heidari, N; Hicks, MA; Marking, CB; Miller, AV | 1 |
3 other study(ies) available for sb 203580 and mifepristone
Article | Year |
---|---|
[The role of MAPK/ERK1/2 signaling pathway in aldosterone stimulated transforming growth factor-beta1 synthesis in renal tubular epithelial cells].
Topics: Aldosterone; Anthracenes; Blotting, Western; Butadienes; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; Imidazoles; Kidney Tubules, Proximal; Mifepristone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Phosphorylation; Pyridines; Signal Transduction; Time Factors; Transforming Growth Factor beta1 | 2006 |
Glucocorticoid rapidly enhances NMDA-evoked neurotoxicity by attenuating the NR2A-containing NMDA receptor-mediated ERK1/2 activation.
Topics: Animals; Blotting, Western; Calcium; Cells, Cultured; Enzyme Inhibitors; Flavonoids; Glucocorticoids; Hippocampus; Imidazoles; Mifepristone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; N-Methylaspartate; Neurons; p38 Mitogen-Activated Protein Kinases; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2010 |
Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Binding Sites; Cell Line, Tumor; Core Binding Factor Alpha 1 Subunit; Dexamethasone; Glucocorticoids; HEK293 Cells; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Membrane Proteins; Mifepristone; p38 Mitogen-Activated Protein Kinases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Pyridines; Receptors, Glucocorticoid; RNA Interference; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2012 |